What is the appropriate treatment plan and investigations for a gastrointestinal (GI) bleed?

Treatment Plan and Investigations for GI Bleeding

The management of GI bleeding begins with immediate hemodynamic assessment using shock index (heart rate/systolic BP), followed by risk stratification to determine whether the patient requires urgent intervention, hospital admission, or can be safely discharged for outpatient investigation. 1

Initial Assessment and Risk Stratification

Calculate the shock index immediately upon presentation. A shock index >1 defines hemodynamic instability and mandates aggressive resuscitation and urgent investigation. 1

For stable patients with lower GI bleeding, use the Oakland score to categorize bleeds as major or minor:

• Oakland score ≤8 points: Minor self-terminating bleed—discharge for urgent outpatient investigation if no other admission indications 1
• Oakland score >8 points: Major bleed—admit for hospital-based colonoscopy 1

Resuscitation and Blood Product Management

Use restrictive transfusion thresholds to reduce mortality:

• Hemoglobin trigger of 70 g/L with target 70-90 g/L for stable patients
• Hemoglobin trigger of 80 g/L with target 100 g/L for patients with cardiovascular disease 1

This restrictive approach has been shown to improve outcomes compared to liberal transfusion strategies, particularly in upper GI bleeding.

Investigation Algorithm

For Hemodynamically Unstable Patients (Shock Index >1)

Proceed directly to CT angiography (CTA) as the fastest, least invasive method to localize bleeding before planning endoscopic or radiological therapy. 1

Critical timing: If interventional radiology is available 24/7, catheter angiography with embolization should occur within 60 minutes of positive CTA for unstable patients. 1

Important caveat: Lower GI bleeding with hemodynamic instability may actually originate from an upper GI source. If CTA shows no lower source, perform upper endoscopy immediately. If the patient stabilizes after resuscitation, gastroscopy may be the first investigation. 1

For Stable Patients with Major Bleeding

Admit for colonoscopy as the primary diagnostic and therapeutic modality. 1

For upper GI bleeding specifically, esophagogastroduodenoscopy within 24 hours is the standard approach, with endoscopic hemostasis for high-risk lesions (active bleeding, visible vessel, adherent clot). 2, 3

For Obscure or Persistent Bleeding

If initial endoscopy and imaging are negative:

• Video capsule endoscopy should be performed within 48 hours of bleeding onset (diagnostic yield 87-91.9% when done early, dropping to <50% after 3 days) 1
• Consider CT enterography or MR enterography for small bowel evaluation 4

Anticoagulation Management

Interrupt warfarin at presentation. For unstable hemorrhage, reverse with prothrombin complex concentrate and vitamin K. 1

Timing of anticoagulation resumption:

• Low thrombotic risk: Restart warfarin at 7 days post-hemorrhage 1
• High thrombotic risk (prosthetic metal mitral valve, AF with prosthetic valve, <3 months post-VTE): Consider low molecular weight heparin at 48 hours 1

Antiplatelet Management

Aspirin for primary prevention: Permanently discontinue 1

Aspirin for secondary prevention: Do not routinely stop. If stopped, restart as soon as hemostasis is achieved. 1

Dual antiplatelet therapy: Management should balance thrombotic vs bleeding risk, with cardiology consultation for high-risk patients.

Pharmacologic Therapy

For upper GI bleeding:

• Proton pump inhibitor (PPI) upon presentation, with high-dose PPI for 72 hours post-endoscopy for high-risk peptic ulcer disease 3, 5
• Erythromycin pre-endoscopy to improve visualization 3

For variceal bleeding (if suspected):

• Prophylactic antibiotics immediately
• Vasoactive medications (octreotide or terlipressin) before endoscopy 3

Do NOT use tranexamic acid—it has not shown benefit and may increase thrombotic complications. 3

Surgical Intervention

No patient should proceed to emergency laparotomy unless every effort has been made to localize bleeding by radiological and/or endoscopic modalities. Surgery is reserved for exceptional circumstances only. 1

The preferred sequence for failed endoscopic hemostasis is:

1. Repeat endoscopy
2. Transcatheter arterial embolization
3. Surgery only if above measures fail 5

Common Pitfalls to Avoid

• Don't assume lower GI bleeding is actually lower—up to 15% of presumed lower GI bleeds originate from upper sources, especially in unstable patients
• Don't delay CTA in unstable patients waiting for endoscopy availability
• Don't perform nasogastric tube placement routinely—it doesn't reliably aid diagnosis, doesn't affect outcomes, and causes complications in one-third of patients 1
• Don't repeat CTA if the first is negative unless bleeding becomes more brisk—nuclear medicine studies or capsule endoscopy are better next steps 1